Patents by Inventor Tohru Takada

Tohru Takada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents comprising midkine or an inhibitor thereof as active ingredient
    Patent number: 7390491
    Abstract: Midkine (MK), which is a retinoic acid-inducible heparin-binding growth factor, enhances neutrophilic migration and exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be used for treating neutrophilic functional disorders or inflammatory diseases.
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: June 24, 2008
    Assignee: Takashi Muramatsu
    Inventors: Tohru Takada, Kazuhiro Toriyama, Hisako Muramatsu, Takashi Muramatsu
  • Agents comprising midkine or its inhibitor as active ingredient
    Publication number: 20030072739
    Abstract: Midkine (MK), which is a retinoic acid-inducible heparin-binding growth factor, enhances neutrophilic migration and exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be used for treating neutrophilic functional disorders or inflammatory diseases.
    Type: Application
    Filed: November 18, 2002
    Publication date: April 17, 2003
    Inventors: Tohru Takada, Kazuhiro Toriyama, Hisako Muramatsu, Takashi Muramatsu
  • Article stocker
    Patent number: D534217
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: December 26, 2006
    Assignee: Sega Corporation
    Inventors: Wataru Yoshizaki, Tohru Takada